tiprankstipranks
Advertisement
Advertisement

Wellgistics Secures Preferred Pricing to Advance EBV Platform

Story Highlights
  • Wellgistics signed a three-year revenue-sharing deal with Kare PharmTech on March 6, 2026 to distribute Kare Verify eligibility and benefits verification services through its extensive pharmacy and digital channels.
  • The company secured preferred pricing for insurance eligibility and benefits verification, immediately offering discounted EBV via EinsteinRx to drive new revenue, lower internal costs and accelerate PharmacyChain adoption in a growing U.S. EBV market.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Wellgistics Secures Preferred Pricing to Advance EBV Platform

Claim 30% Off TipRanks

Wellgistics Health Inc ( (WGRX) ) just unveiled an announcement.

Wellgistics Health, Inc., a NASDAQ-listed health information technology firm focused on AI-enabled pharmacy dispensing and blockchain smart contracts for the U.S. prescription drug market, operates an integrated platform that links more than 6,500 pharmacies and over 200 manufacturers. The company delivers wholesale distribution, digital prescription routing, direct-to-patient delivery and AI-powered hub services to restore access, transparency and trust for independent pharmacies.

On March 6, 2026, Wellgistics entered into a 36‑month Interim Commercialization and Revenue Share Agreement with Kare PharmTech LLC to market, promote and distribute Kare Verify, a medical insurance eligibility and benefits verification product, through its pharmacy, manufacturer and telemedicine channels on a 50/50 net revenue split. In a March 11, 2026 announcement, Wellgistics said it secured preferred pricing rights for eligibility and benefits verification services, immediately making discounted EBV access available via its EinsteinRx AI hub, a move expected to open a new revenue stream, reduce its own pharmacy costs and accelerate adoption of its PharmacyChain platform in a U.S. EBV market projected to grow from $2.39 billion in 2025 to $3 billion by 2030.

Wellgistics highlighted that EBV capabilities are a core requirement for PharmacyChain’s market adoption because they determine insurance coverage, reimbursement levels and patient out-of-pocket costs for medical products and services. Management indicated that the pricing certainty and technical integration of EBV into PharmacyChain will support coding and deployment of its “health technology railroad” smart contracts across the drug distribution supply chain, positioning EBV as a meaningful contributor to revenue starting in the second quarter of 2026.

More about Wellgistics Health Inc

Wellgistics Health, Inc. is a U.S. health information technology company that integrates its proprietary EinsteinRx AI pharmacy dispensing optimization platform with its patented blockchain-enabled PharmacyChain smart contracts system to streamline prescription drug dispensing. The company connects more than 6,500 pharmacies and over 200 manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery and AI-powered hub services focused on eligibility, adherence, onboarding, prior authorization and cash-pay fulfillment for independent pharmacies.

Its integrated platform is designed to improve access, transparency and trust in the U.S. prescription drug market by optimizing reimbursement workflows and patient access to therapies. Through the Wellgistics Pharmacy Network, the company provides end-to-end digital and distribution solutions that target operational efficiency for pharmacies and manufacturers while enhancing the patient experience in an increasingly complex healthcare billing and coverage environment.

Average Trading Volume: 868,715

Technical Sentiment Signal: Strong Sell

Current Market Cap: $16.33M

Find detailed analytics on WGRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1